| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.018 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |